Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Travis S |
Review article: saving the colon in severe colitis - the case for medical therapy. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16961749
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
McSharry K et al. |
Systematic review: the role of tacrolimus in the management of Crohn's disease. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21999607
|
Beckebaum S et al. |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. |
2009 |
Aliment. Pharmacol. Ther. |
pmid:19624550
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Yamamoto T et al. |
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137731
|
Laharie D and Poullenot F |
Letter: which patient profile for tacrolimus in ulcerative colitis? |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137730
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|